Cytisinicline

5 trials 2 recruiting NNeurology/Psychiatry

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

3 Completed trials

3 Sponsors

3 Countries

Phase IV

Phase I (Other)

Phase IV: 2 Phase I (Other): 3

Indications tested

Chronic kidney disease 1 Nicotine dependence 1

Sponsors using this IMP

Achieve Life Sciences Inc. 3 Fundacion Publica Galega Instituto De Investigacion Sanitaria De Santiago De Compostela 1 Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy 1

All trials

5 total

Phase IV, randomized, open-label, open-label, controlled, parallel, multicenter clinical trial in patients who are candidates for smoking ce… Recruiting

2024-518936-36-00 Phase IV 1 country Fundacion Publica Galega Instituto De Investigacion Sanitaria De Santiago De Com…
Cytisine in prolonged dosage versus Nicotine Replacement Therapy in nicotine-dependent patients with Chronic Kidney Disease - single-center,… Recruiting

2023-509235-39-00 Phase IV 1 country Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Bada…
A Phase 1 Study to Investigate the Effect of Food on the Bioavailability of a Single Cytisinicline 3 mg Tablet and Evaluation of the Pharmac… Ended

2023-504260-42-00 Phase I (Other) 1 country Achieve Life Sciences Inc.
A Phase I, Open-Label Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytis… Ended

2022-500921-34-00 Phase I (Other) 2 countries Achieve Life Sciences Inc.
A Four Way Crossover Thorough QT/QTc Study to Evaluate the Electrocardiographic Effects of Therapeutic and Supratherapeutic Doses of Cytisin… Ended

2022-500954-40-00 Phase I (Other) 1 country Achieve Life Sciences Inc.

Showing 1–5 of 5 trials

← All drugs A–Z